Brightstar Partners
Brightstar Partners, established in 2002 and located in Cambridge, United Kingdom, is a venture capital and development firm focused on early-stage investments in technology start-ups, particularly in the fields of medical devices, diagnostics, and digital systems. The team at Brightstar combines extensive experience in technology spin-outs from corporate labs with a strong entrepreneurial background. Their expertise spans strategy, intellectual property commercialization, corporate finance, negotiations, and legal structuring. Brightstar Partners aims to support early opportunities by refining business propositions and enhancing commercialization strategies, thereby providing essential skills and experience to emerging ventures.
Regenerys
Venture Round in 2016
Regenerys Ltd. specializes in developing and selling regenerative medicine products focused on bioprocessing and biostorage. The company offers several innovative products, including Myskin, which uses cultured cells from a patient's own skin for treating serious burns and hard-to-heal wounds, and Cryoskin, which employs autologous cells for burn treatment. Additionally, Regenerys provides Adiposet, a service that enhances cosmetic outcomes in breast cancer surgeries and other aesthetic procedures by enabling the storage and return of adipose tissue. The company also delivers third-party bioprocessing and biostorage services through its laboratories. Serving both NHS and private healthcare providers, Regenerys operates primarily in the United Kingdom and Europe. Established in 2011, the company is headquartered in Cambridge, United Kingdom.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at
support@teaserclub.com. Your feedback is most welcome.